ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 588,30
-0,58%
Dow Jones
40 211,72
0,53%
DAX
18 519,95
-0,43%
Brent Oil
83,655
-0,81%
Bitcoin
63 194,70
-2,55%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
28/06/202117h46Business WireTeva et Bioeq annoncent un partenariat commercial dans le domaine des biosimilairesNYSE:TEVATeva Pharmaceutical Industries Ltd
28/06/202114h00Business WireTeva and Bioeq Announce Commercial Partnership for BiosimilarNYSE:TEVATeva Pharmaceutical Industries Ltd
23/06/202114h12Business WireTeva Announces Ministry of Health, Labour & Welfare Approves AJOVY® (fremanezumab) Injection in Japan for the Preventive Tre...NYSE:TEVATeva Pharmaceutical Industries Ltd
23/06/202108h58Business WireNouvelles données relatives à l'innocuité du traitement par COPAXONE® (acétate de glatiramère) chez les mères allaitan...NYSE:TEVATeva Pharmaceutical Industries Ltd
22/06/202123h18Business WireTeva Announces Its Launch of the First Generic PERFOROMIST®, Formoterol Fumarate Inhalation Solution, 20 mcg/2 ML, Used to T...NYSE:TEVATeva Pharmaceutical Industries Ltd
22/06/202116h36Business WireNeue Sicherheitsdaten zur Behandlung von stillenden Müttern mit COPAXONE® (Glatirameracetat), die mit schubförmig verlaufe...NYSE:TEVATeva Pharmaceutical Industries Ltd
22/06/202110h17Business WireTeva présente de nouvelles données lors du 7e congrès de l’Académie européenne de neurologie, suggérant que des facte...NYSE:TEVATeva Pharmaceutical Industries Ltd
22/06/202108h30Business WireNew Safety Data on treatment with COPAXONE® (glatiramer acetate) of Breastfeeding Mothers who Live with Relapsing Multiple S...NYSE:TEVATeva Pharmaceutical Industries Ltd
22/06/202107h24Business WireTeva präsentiert neue Daten auf dem 7. Kongress der European Academy of Neurology, die sozioökonomische Faktoren mit einer ...NYSE:TEVATeva Pharmaceutical Industries Ltd
22/06/202104h55Business WireDe nouvelles données étayant le profil d’innocuité et d’efficacité d’AJOVY® (frémanezumab) partagées lors du 7e ...NYSE:TEVATeva Pharmaceutical Industries Ltd
22/06/202104h54Business WireNeue Daten, die das Sicherheits- und Wirksamkeitsprofil von AJOVY® (Fremanezumab) stützen, werden auf dem 7. Kongress der E...NYSE:TEVATeva Pharmaceutical Industries Ltd
21/06/202114h01Business WireTeva Presents New Data at 7th European Academy of Neurology Congress Suggesting Socio-Economic Factors May Contribute to the ...NYSE:TEVATeva Pharmaceutical Industries Ltd
21/06/202114h01Business WireNew Data Supporting the Safety & Efficacy Profile of AJOVY® (fremanezumab) Shared at 7th European Academy of Neurology Congr...NYSE:TEVATeva Pharmaceutical Industries Ltd
16/06/202114h23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:TEVATeva Pharmaceutical Industries Ltd
16/06/202113h36Business WireTeva Announces the U.S. Launch of its Generic Version of SOOLANTRA® (ivermectin) Cream, 1% for Once Daily Treatment of RosaceaNYSE:TEVATeva Pharmaceutical Industries Ltd
03/06/202114h15Business WireNew Clinical & Real-World Data Evaluating Efficacy of AJOVY® (fremanezumab-vfrm) Injection Presented at 2021 American Headac...NYSE:TEVATeva Pharmaceutical Industries Ltd
03/06/202114h00Business WireTeva to Present Latest Data on AJOVY® (fremanezumab-vfrm) Injection at the 2021 American Headache Society (AHS) Annual Meeti...NYSE:TEVATeva Pharmaceutical Industries Ltd
17/05/202119h03Business WireTeva Announces the U.S. Launch of the First Generic Version of THIOLA® (tiopronin) tabletsNYSE:TEVATeva Pharmaceutical Industries Ltd
17/05/202114h00PR Newswire (US)Teva Launches 'It's Not OK - It's TD' National Television Advertising Campaign to Increase Awareness of Tardive Dyskinesia an...NYSE:TEVATeva Pharmaceutical Industries Ltd
10/05/202114h00Business WireTeva to Highlight Research in Respiratory Care at Upcoming 2021 American Thoracic Society International ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
05/05/202114h00Business WireTeva Announces New Environmental, Social and Governance (ESG) Strategy and Goals in 2020 ReportNYSE:TEVATeva Pharmaceutical Industries Ltd
04/05/202117h14Business WireTeva Announces Launch of its Generic Erythromycin Tablets USP, Used to Treat or Prevent a Variety of Bacterial Infections, in...NYSE:TEVATeva Pharmaceutical Industries Ltd
03/05/202114h00Business WireTeva to Present New Long-Term AUSTEDO® (deutetrabenazine) Tablets Data at American Psychiatric Association Annual MeetingNYSE:TEVATeva Pharmaceutical Industries Ltd
29/04/202122h18Business WireTeva Announces the Launch of the First Generic Version of Absorica® (isotretinoin) Capsules, for the Treatment of Severe Rec...NYSE:TEVATeva Pharmaceutical Industries Ltd
28/04/202122h08Edgar (US Regulatory)Quarterly Report (10-q)NYSE:TEVATeva Pharmaceutical Industries Ltd
28/04/202113h01Edgar (US Regulatory)Current Report Filing (8-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
28/04/202113h00Business WireTeva Reports First Quarter 2021 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
27/04/202114h00Business WireTeva to Present New Analyses of AUSTEDO® (deutetrabenazine) Tablets & Assessment of Schizophrenia Clinical Outcomes at Upcom...NYSE:TEVATeva Pharmaceutical Industries Ltd
23/04/202117h09Business WireTeva Announces Launch of its Generic Version of Canasa® (mesalamine) Suppositories To Treat Adults with Active Ulcerative Pr...NYSE:TEVATeva Pharmaceutical Industries Ltd
21/04/202122h12Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

TSXV
CTW
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés